A Dose Escalation Study to Assess the Efficacy and Safety of Bradanicline in Subjects With Refractory Chronic Cough
Phase of Trial: Phase II
Latest Information Update: 14 Jan 2019
At a glance
- Drugs Bradanicline (Primary)
- Indications Cough
- Focus Proof of concept; Therapeutic Use
- Sponsors Attenua
- 14 Nov 2018 According to an Attenua Inc media release, first patient has been treated in this trial.
- 05 Nov 2018 Status changed from not yet recruiting to recruiting.
- 06 Aug 2018 Status changed from planning to not yet recruiting.